Advent International to acquire a 50.01% stake in  Suven Pharmaceuticals

Advent International; the Global private equity firm said in a statement on 26th December that it is acquiring a 50.01% stake in Hyderbad’s Suven Pharmaceuticals

Advent International also plans to launch an open offer for an additional 26% stake in Suven Pharmaceuticals at Rs. 495 shares.